News

Clock genes are a set of genes known to contribute to the regulation of the human body's internal 24-hour cycle, also known ...
HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers ...
Around 10 million people globally live with the life-threatening virus HTLV-1. Yet it remains a poorly understood disease ...
According to a new comprehensive report from The Insight Partners, the global patient-derived xenograft model market is ...
SHELTON, CT / ACCESS Newswire / July 21, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC ) (the ...
Scientists have developed a novel method to generate billions of rare immune cells known as conventional type I dendritic ...
Renovaro (NASDAQ: RENB) is a TechBio company combining advanced machine learning with breakthrough immunotherapies to transform how cancer and other diseases are detected and treated. Through ...
Oncology, a team of expert scientists specializing in immuno-oncology extensively outlined the complexities involved in the ...
NanoViricides, Inc. (NYSE American: NNVC) , a clinical-stage developer of broad-spectrum antivirals using host-mimetic nanomedicine, announced promis ...
Landmark preclinical data validate Renovaro's platform representing a step forward in the fight against pancreatic and solid ...